Comparison of Transverse and Longitudinal Incisions for Venous Access Port Placement
Launched by JAGIELLONIAN UNIVERSITY · Jan 4, 2025
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different ways to make an incision in the skin when placing a central venous access port, which is a device used to give medication or draw blood. The researchers want to find out if the direction of the incision—either across (transverse) or up and down (longitudinal)—affects how much pain patients feel within the first day, how comfortable they are a week later, how long the procedure takes, and if there are any early complications after the port is placed.
To join this study, participants need to be between 18 and 80 years old, able to give informed consent, and require this type of port placement under local anesthesia. However, some people may not be eligible if they have certain health issues, such as problems with blood clotting or a history of specific conditions. If you decide to participate, you can expect to be closely monitored for pain and comfort levels after the procedure, and your experience will help researchers understand the best approach for this important medical procedure.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Inclusion Criteria:
- • Age \> 18 and \< 80 years Informed consent Need for central venous access port implementation under local anesthesia
- Exclusion Criteria:
- • Impaired blood clotting Ongoing antiplatelet drugs therapy, except acetylsalicylic acid Trauma or surgical past history on both shoulder girdles Known central venous thrombosis (subclavian vein, upper vena cava) Known pneumothorax Septic state Agranulocytosis
About Jagiellonian University
Jagiellonian University, one of the oldest and most prestigious institutions of higher education in Poland, is a leading sponsor of clinical trials dedicated to advancing medical research and healthcare innovation. With a strong commitment to scientific excellence, the university leverages its extensive resources, multidisciplinary expertise, and collaborative network to conduct rigorous clinical studies that contribute to the development of new therapies and treatment strategies. Jagiellonian University emphasizes ethical research practices and strives to enhance patient outcomes through evidence-based findings, making significant contributions to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cracow, , Poland
Cracow, , Poland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported